TELES AG INFORMATIONSTECHNOLOGIEN Quarterly Financial Statements Q3-2022 of the TELES Group
(IFRS, unaudited)
Key figures from January 1, 2022 to September 30, 2022
- Sales growth to EUR 58.8 million (previous year: EUR 1,680 thousand)
- Gross profit of EUR 3.8 million (previous year: EUR 1,288 thousand)
- EBITDA of EUR 149 thousand (previous year EUR -155 thousand)
Overview of the corporate key figures of TELES Group for Q3-2022 (in accordance with IFRS, unaudited)
TELES Group | 01.01.2021 - | 01.01.2022 - | Change |
in thousand Euro | 30.09.2021 | 30.09.2022 | |
Sales revenues | 1,680 | 58,809 | > +500% |
Cost of materials | 392 | 55,002 | > +500% |
Personnel expenses | 1,123 | 2,475 | 120% |
Gross profit | 354 | 1,293 | 265% |
Operating result/EBIT | -290 | -163 | 44% |
EBITDA | -155 | 149 | 196% |
Group result | -309 | -484 | -57% |
© TELES AG | ||
Page 1 of 9 | ||
October 2022 | ||
Interim Management Report
With the Pharma expansion field, TELES opened up a new segment at the end of 2021, in which, as in telecommunications software, the management of large amounts of data and the digitization of business processes lead to growth spurts.
The earnings situation of the TELES Group improved significantly in the first nine months of 2022 compared to the same period of the previous year. The reason for this is in particular the inclusion of EURO RX Arzneimittel GmbH in the consolidated financial statements since January 2022. The TELES Group achieved sales revenues of EUR
58.8 million (previous year: EUR 1,680 thousand). Gross profit increased accordingly to EUR 3.8 million (previous year: EUR 1,288 thousand).
Personnel expenses increased by 120 % to EUR 2.48 million (previous year: EUR 1,123
thousand). Depreciation was EUR 313 thousand (previous year: EUR 135 thousand).
Other operating income was EUR 110 thousand (previous year: EUR 34 thousand). With
the increase in other operating expenses of EUR 1,293 (previous year: EUR 354), the
EBITDA was EUR 149 thousand (previous year: EUR -155 thousand) and the consoli-
dated result at EUR -484 thousand (previous year: EUR -309 thousand).
The balance sheet total of TELES increased by EUR 10.3 million compared to the previous year. This is due in particular to the increase in current assets by EUR 9.4 million.
In the cash flow statement, the operating cash flow is EUR 2.0 million (previous year: EUR -24 thousand). The investment activity of EUR 1,870 thousand is primarily characterized by investments in fixed assets for EURO RX Arzneimittel GmbH and the extension of the lease at TELES. As of September 30, 2022, the funds were EUR 1.4 million (previous year: EUR 632 thousand).
© TELES AG | ||
Page 2 of 9 | ||
October 2022 | ||
Risk Report
In the management report for the past 2021 fiscal year, all relevant risks known to us were listed conscientiously. Nothing to add now. We ensure the company's liquidity through very conscientious planning. We continue to monitor incoming payments very closely and thus counteract payment defaults on the part of customers. Whether the sales and earnings targets will be achieved depends - apart from internal company factors - to a significant extent on economic, political and industry-specific developments − particularly in our core market of Europe.
Forecast
For the current fiscal year we expect sales of EUR 65 to 75 million and a neutral result (EBIT) for the TELES Group.
TELES Aktiengesellschaft
Oliver Olbrich
Chief Executive Officer
October 2022
© TELES AG | ||
Page 3 of 9 | ||
October 2022 | ||
Interim Financial Statements
Consolidated Balance Sheet (IFRS, unaudited)
in thousand Euro | 31.12.2021 | 30.09.2022 | |
Assets | |||
A. | Fixed assets | ||
I. | Intangible assets | 0 | 57 |
II. | Tangible assets | 64 | 1,054 |
III. | Rights of use from leasing agreements | 186 | 1,319 |
IV. | Financial assets | 1,894 | 582 |
Total fixed assets | 2,144 | 3,012 | |
B. | Current assets | ||
I. | Stocks | 5 | 3,823 |
II. | Trade receivables and other receivables | 351 | 3,510 |
III. | Other assets | 95 | 1,509 |
IV. Cheque, Cash at bank and in hand | 391 | 1,396 | |
Total current assets | 842 | 10,237 | |
Prepayments and accrued income | 48 | 51 | |
Total assets | 3,034 | 13,300 | |
© TELES AG | ||
Page 4 of 9 | ||
October 2022 | ||
in thousand Euro | 31.12.2021 | 30.09.2022 | |
Equity and liabilities | |||
A. | Equity | ||
I. | Ordinary shares | 6,233 | 6,233 |
II. | Capital reserve | 242 | 242 |
III. | Revenue reserves | ||
Loss carried forward | -4,906 | -4,906 | |
Profit or loss for the period | 0 | -485 | |
Total equity | 1,569 | 1,085 | |
B. | Minority interest | 0 | 365 |
C. | Provisions | ||
I. | Tax provisions | 625 | 971 |
II. | Other provisions | 156 | 425 |
Total provisions | 780 | 1,396 | |
D. | Creditors | ||
I. | Financial liabilities | 0 | 8,299 |
II. | Payment received on account | 58 | 28 |
III. | Trade creditors | 210 | 408 |
IV. | Leasing liabilities | 227 | 1,360 |
V. | Other creditors | 61 | 211 |
Total creditors | 556 | 10,306 | |
E. | Deferred income | 129 | 144 |
F. | Deferred taxes | 0 | 4 |
Total equity and liabilities | 3,034 | 13,300 | |
© TELES AG | ||
Page 5 of 9 | ||
October 2022 | ||
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
TELES AG Informationstechnologien published this content on 07 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 November 2022 13:13:05 UTC.
